Return to homepagePandemic Pact

COVID-19 Immuonogenicty ELISA for Community Surveillance

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    BIRAC

  • Principal Investigator

    Arumugam Muruganandam

  • Research Location

    India

  • Lead Research Institution

    Affigenix Biosolutions Pvt Ltd

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Our ELISA kit can diagnose large number of samples within a very short duration ~30mins for 90 samples . The immunogenicity test for COVID-19 is a bridge ELISA method to quantitatively determine the total anti-covid immunoglobulin IgG, IgA, IgM, IgE and IgD response in the samples without revealing the stage of infections as recent exposure to COVID 19 or later stage of infections. By using cocktail of viral antigen as capture and detection to quantitatively determine the anti-COVID antibody in the serum, our approach offer a major advantage to overcome any present or future mutations in strain or isolation, and help generate a robust diagnostic assay for use in low resource testing as well as in highly established labs